Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0038389992
Fri, 25.07.2025
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
July 25, 2025
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at June 30, 2025, which covers the results of its business activities for the first six months of 2025.
Based on the consolidated accounts of BB Biotech AG, net loss for the [ … ]
Fri, 25.07.2025
BB BIOTECH AG
Media release as at July 25, 2025
BB Biotech Q2 2025: outperforms Nasdaq Biotech Index; strong USD returns, currency drag in CHF
Share price +10.2 % USD / -1.1% CHF / +0.8% EUR; discount to NAV tightens to 10.5%
NAV +5.8% USD / -5.1% CHF / -2.8% EUR; beating NBI by 5.9 percentage points
Net loss of CHF 100 mn in Q2; FX the main drag (USD vs CHF [ … ]
Tue, 10.06.2025
Edison Investment Research Limited
London, UK, 10 June 2025
Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (BION).
During 2024 and early this year, the biotech sector began to show signs of a structural recovery, supported by positive clinical data, regulatory approvals, lower interest rates, commercial execution and Johnson & Johnson’s acq [ … ]
Fri, 25.04.2025
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
April 25, 2025
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at March 31, 2025, which covers the results of its business activities for the first three months of 2025.
Based on the consolidated accounts of BB Biotech AG, net loss for [ … ]
Fri, 25.04.2025
BB BIOTECH AG
Media release as at April 25, 2025
BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility
The first quarter of 2025 was marked by elevated market volatility and rising macro uncertainty, driven by geopolitical developments and trade tensions. Biotech valuations, especially in small- and mid-cap names, remained under pressu [ … ]
Wed, 19.03.2025
BB BIOTECH AG
Media release of March 19, 2025
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share
All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting held today.
Shareholders voted in favor of the proposal to pay out a divi [ … ]
Fri, 21.02.2025
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
February 21, 2025
Annual report of BB Biotech AG as at December 31, 2024
BB Biotech AG publishes its 2024 annual report
BB Biotech AG published its annual report for fiscal year 2024 today. Besides the audited consolidated financial statements, the annual report contains detailed information on the bi [ … ]
Fri, 21.02.2025
BB BIOTECH AG
Media release as at February 21, 2025
Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics
2024, especially the fourth quarter, signaled the early stage of a structural recovery in biotech, driven by renewed investor focus on clinical data, regulatory approvals, and commercial execution.
BB Biotec [ … ]
Fri, 24.01.2025
BB BIOTECH AG
Media release as of January 24, 2025
BB Biotech: Preliminary full-year 2024 results and dividend proposal
BB Biotech AG reports the following preliminary and unaudited figures for 2024:
Full-year 2024: BB Biotech shares delivered a total return of -13.5% in CHF and -14.1% in EUR (including the CHF 2.00 dividend paid in March 2024). NAV performan [ … ]
Fri, 24.01.2025
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
January 24, 2025
BB Biotech AG closes the 2024 fiscal year with a profit
In accordance with regulations on ad hoc publicity, BB Biotech AG (ISIN CH0038389992) is releasing the following information:
Based on its preliminary unaudited consolidated figures, BB Biotech AG reports a profit of approximately [ … ]
